August 15, 2014

Pfizer’s Prevnar 13 vaccine for pneumonia has been recommended for use by patients 65 years old and up by the Centers for Disease Control and Prevention’s immunization practices advisory committee. 

August 15, 2014

The Food and Drug Administration announced approval of a new use for Avastin (bevacizumab), to treat patients with persistent, recurrent or late-stage cervical cancer.

August 15, 2014

Three-in-five U.S. adults are not aware of the importance of the high-dose flu vaccine in flu prevention for adults ages 65 years and older.

August 15, 2014

The second annual health survey by the Pharmaceutical Research and Manufacturers of America shows that Americans are more conscious of their health, and believe their own health is good.

August 14, 2014

Amneal Pharmaceuticals announced four new additions to its portfolio of generic drugs, which represent multiple therapeutic categories and account for $900 million annually in U.S. sales, the company said, citing data from IMS Health.

August 14, 2014

The Food and Drug Administration has announced approval for Belsomra (suvorexant) tablets, which are used to treat insomnia.

August 14, 2014

Medicare’s Annual Wellness Visits present potential opportunities for pharmacists based in physician offices, concluded two experience articles published in the July/August 2014 edition of the Journal of the American Pharmacists Association.

August 14, 2014

DAVIE, Fla. — Private healthcare organization CarePredict has introduced Tempo, a wrist-worn sensor that records such daily living activities as quality and amount of sleep, bathing, eating, drinking, cooking and more, to help seniors live an independent life.

August 14, 2014

Pragma Pharmaceuticals announced the relaunch of Moxatag (amoxicillin extended-release tablets), 775 mg.

August 14, 2014

High-dose influenza vaccine is 24% more effective than the standard-dose vaccine in protecting persons ages 65 and older against influenza illness and its complications, according to a Vanderbilt-led study published Wednesday in the New England Journal of Medicine.

August 14, 2014

Tummy Co. recently launched a fast-acting liquid antacid in a shot format called Relief OTC, the company announced Wednesday.

August 14, 2014

Beginning in August, Wegmans Food Markets is now offering an enhanced Specialty Pharmacy Service for medications used to treat conditions in the fields of rheumatology, gastroenterology, neurology and dermatology.

August 13, 2014

The majority of Americans report they have had a good year when it comes to their personal health, and are paying more attention to their health compared to just a few years ago, according to From Hope to Cures: PhRMA’s Second Annual National Health Survey. 

August 13, 2014

The Arthritis Society has partnered with McKesson Canada's four retail banners Guardian, I.D.A., PROXIM and the Medicine Shoppe Canada pharmacies to launch an exclusive pain management program to support Canadians living with arthritis directly in their communities.

 

August 13, 2014

Walgreens on Wednesday announced it is expanding its Healthcare Clinic retail locations with entry into the Dallas-Fort Worth market. 

 

August 12, 2014

According to a Reuters report published Tuesday, Apple is in talks with health providers, including Mount Sinai, the Cleveland Clinic and Johns Hopkins, around its "HealthKit" service. 

 

August 12, 2014

Rite Aid is getting a head start on the 2014-15 cold and flu season with the announcement Tuesday that seasonal flu shots are now available at Rite Aid pharmacies nationwide. 

 

August 12, 2014

Sanofi on Tuesday announced that it has launched an authorized generic version of Eloxatin (oxaliplatin injection) through Winthrop U.S., the company’s generics division. 

August 12, 2014

In the largest study of its kind, researchers last week suggested that in older people, not getting enough vitamin D may double the risk of developing dementia and Alzheimer's disease. 

August 11, 2014

Janssen Pharmaceuticals received approval from the Food and Drug Administration for Invokamet, a fixed-dose therapy that combines canagliflozin and metformin hydrochloride in a single tablet.

August 11, 2014

The Food and Drug Administration last week released a draft guidance to assist sponsors and other interested parties in providing information that will help the agency determine the exclusivity period for biologics approved under Section 351(a) of the Public Health Service Act, Bloomberg BNA reported.

August 11, 2014

Mylan announced the launch of capecitabine tablets USP in 150-mg and 500-mg dosage strengths, a generic version of Xeloda tablets from Genentech.

August 8, 2014

The Food and Drug Administration earlier this week announced approval for Orbactiv (oritavancin), an antibacterial drug used to treat patients with acute bacterial skin and skin structure infections.

August 8, 2014

Walmart is reportedly making a more aggressive push into medical care by not only planning to open additional clinics but it is also marketing itself as a primary care provider.